Skip to main content
Clinical Trials/NCT06248788
NCT06248788CompletedNot Applicable

Study to Survey the Normal Range of Salivary Immunoglobulin A (sIgA) Levels Measured by a Point of Care Device in Healthy Adult Women and Men

4Life Research, LLC1 site in 1 country47 target enrollmentStarted: June 19, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
47
Locations
1
Primary Endpoint
Salivary IgA

Study Overview

Brief Summary

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adults committed to attend the session and follow the instructions described in Experimental Design will be included.

Exclusion Criteria

  • Participant with mouth infection or oral disease

Outcomes

Primary Outcomes

Salivary IgA

Time Frame: 0 minute

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
4Life Research, LLC
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Salivary Immunoglobulin A (sIgA) Normal... | Clinical Trial